Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Proteinuria in diabetes: bystander or pathway to cardiorenal disease?Karalliedde J; Viberti GJ Am Soc Nephrol 2010[Dec]; 21 (12): 2020-7The development of albuminuria in diabetics is closely associated with an enhanced risk of renal and cardiovascular disease. However, the role of albuminuria in the pathogenesis of these clinical conditions remains controversial. Whether albuminuria is simply a biomarker or qualifies as a surrogate endpoint for cardiorenal disease has wide-ranging implications from the monitoring and treatment of patients to the design of clinical trials and drug development. We critically review available data to determine whether the association between albuminuria and cardiorenal disease is causative. Current evidence suggests the significance of albuminuria depends on its severity (degree or level) and on the specific clinical outcome under consideration. For diabetic kidney disease, there is convincing epidemiologic and experimental evidence to assign clinical albuminuria status as a surrogate endpoint, but for lower levels of albuminuria (microalbuminuria and normoalbuminuria), the evidence is inconclusive or not available. Albuminuria of any degree is unlikely to be causally related to diabetic cardiovascular disease, but its onset might be useful to identify those subjects at cardiovascular risk and to detect and treat other modifiable risk factors.|Albuminuria/diagnosis/*epidemiology[MESH]|Causality[MESH]|Comorbidity[MESH]|Diabetes Mellitus, Type 1/diagnosis/epidemiology[MESH]|Diabetes Mellitus, Type 2/diagnosis/epidemiology[MESH]|Diabetes Mellitus/diagnosis/*epidemiology[MESH]|Diabetic Cardiomyopathies/*epidemiology/physiopathology[MESH]|Diabetic Nephropathies/diagnosis/*epidemiology[MESH]|Disease Progression[MESH]|Female[MESH]|Humans[MESH]|Kidney Function Tests[MESH]|Male[MESH]|Prevalence[MESH]|Prognosis[MESH]|Proteinuria/diagnosis/*epidemiology[MESH]|Risk Assessment[MESH]|Severity of Illness Index[MESH] |